开发和验证一个临床决策支持工具,用于以16α-18F--17β-乙醇为目标的PET成像,以16α-18F-17β-乙醇为目标
Nicholas DiGregorio1, Regina Munter-Young2
1Medical Affairs, GE HealthCare, Marlborough, MA.
Clinical breast cancer
|November 29, 2024
概括
一个新的临床决策支持 (CDS) 工具显示了改善雌激素受体 (ER) 状态评估在乳腺癌 (BC) 管理中的希望. 瘤学家发现该工具是直观的,这表明进一步开发诊断工作是有必要的.
科学领域:
- 在瘤学瘤学.
- 医疗成像医学成像
- 临床决策支持系统 临床决策支持系统
背景情况:
- 雌激素受体 (ER) 状态对于乳腺癌 (BC) 管理至关重要,但免疫组织化学 (IHC) 有局限性.
- 雌醇F18成像为ER表达提供了高准确度,补充了活检数据.
- 开发了一种临床决策支持 (CDS) 工具,以评估其在转移性和复发性BC.中的实用性.
研究的目的:
- 评估概念性CDS工具在转移性和复发性乳腺癌中对ER状态评估的临床有用性.
- 在CDS工具框架内反映临床实践变量.
主要方法:
- 患者的资格取决于治疗候选人和复发率.
- CDS工具使用IF-THEN规则,包括瘤负担,转移位置,异质性和样本准确性.
- 一个基于Excel的决策树计算ER表达式的准确性.
主要成果:
- 360名美国瘤学家接受调查,93%的人认为CDS工具直观易用.
- 与血液瘤学家相比,医疗和临床瘤学家对该工具的偏好更高.
- 关于单个CDS工具属性的积极反,包括临床标准和诊断输入.
结论:
- 瘤学家的反支持进一步开发CDS工具.
- 开发的CDS工具显示了增强乳腺癌患者诊断工作的潜力.
更多相关视频
09:08Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method
Published on: December 20, 2024
1.3K
09:03Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET
Published on: October 22, 2019
9.9K
相关概念视频
Positron Emission Tomography
4.0K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.0K
Imaging Studies II: Positron Emission Tomography and Scintigraphy
86
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
86
